Cargando…

Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden

AIMS: The aim of this study was to establish whether patients with multiple comorbidities may be at elevated risk of hyperkalaemia (HK), a potentially life-threatening electrolyte imbalance, and the associated adverse clinical outcomes. METHODS AND RESULTS: This was a retrospective, observational co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tafesse, Eskinder, Hurst, Michael, Sugrue, Daniel, Hoskin, Louise, Badora, Karolina, Qin, Lei, James, Glen, McEwan, Phil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728036/ https://www.ncbi.nlm.nih.gov/pubmed/33079171 http://dx.doi.org/10.1093/ehjqcco/qcaa078

Ejemplares similares

The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review
por: Bem, Danai, et al.
Publicado: (2021)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
por: Furuland, Hans, et al.
Publicado: (2018)

Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
por: James, Glen, et al.
Publicado: (2021)

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review
por: Ward, Thomas, et al.
Publicado: (2020)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinician surveys
por: Gordon, Jason P., et al.
Publicado: (2015)

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study
por: Pockett, Rhys D., et al.
Publicado: (2015)

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
por: Sugrue, Daniel M., et al.
Publicado: (2019)

Predictors of Tuberculosis and Non-Communicable Disease Comorbidities Among Newly Enrolled Tuberculosis Patients, Southern Ethiopia
por: Nunemo, Mengistu Handiso, et al.
Publicado: (2023)

Comorbidity Burden and Adverse Outcomes After Transcatheter Aortic Valve Replacement
por: Feldman, Daniel R., et al.
Publicado: (2021)

Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
por: Linde, Cecilia, et al.
Publicado: (2019)

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
por: Darlington, Oliver, et al.
Publicado: (2021)

Potassium Intake—(Un)Expected Non-Predictor of Higher Serum Potassium Levels in Hemodialysis DASH Diet Consumers
por: Garagarza, Cristina, et al.
Publicado: (2022)

Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2
por: O’Hare, A. M., et al.
Publicado: (2021)

Context-dependant enhancers as a reservoir of functional polymorphisms and epigenetic markers linked to alcohol use disorders and comorbidities
por: MacKenzie, Alasdair, et al.
Publicado: (2022)

What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient
por: Strain, W. David, et al.
Publicado: (2020)

The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021)

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
por: Theuns, Dominic A.M.J., et al.
Publicado: (2011)

Treatment related toxicity in BRCA1-associated epithelial ovarian cancer – is DNA repairing impairment associated with more adverse events?
por: Badora-Rybicka, Agnieszka, et al.
Publicado: (2016)

Association Between Dietary Potassium Intake and Serum Potassium in CKD
por: Brown, Robert S.
Publicado: (2023)

Assessment of serum glucose potassium ratio as a predictor for morbidity and mortality of blunt abdominal trauma
por: Katipoğlu, Burak, et al.
Publicado: (2022)

Electroconvulsive therapy and serum potassium.
por: McCleane, G. J., et al.
Publicado: (1989)

Economic Burden of COPD in the Presence of Comorbidities
por: Mannino, David M., et al.
Publicado: (2015)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

The burden of comorbidities in pulmonary arterial hypertension
por: Lang, Irene M, et al.
Publicado: (2019)

Frailty and comorbidity burden in Atrial Fibrillation
por: Salis, Francesco, et al.
Publicado: (2023)

Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
por: Neri, Luca, et al.
Publicado: (2012)

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
por: Gordon, Jason, et al.
Publicado: (2020)

Response to “Association Between Dietary Potassium Intake and Serum Potassium in CKD”
por: Ogata, Soshiro, et al.
Publicado: (2023)

Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective
por: Whalley, Diane, et al.
Publicado: (2018)

Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2020)

Should we consider serum potassium level as a mortality predictor in ST-elevation myocardial infarction?
por: Eyüboğlu, Mehmet
Publicado: (2015)

The financial burden of out of pocket payments on medicines among households in Ethiopia: analysis of trends and contributing factors
por: Mekuria, Getahun Asmamaw, et al.
Publicado: (2023)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017)

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
por: Evans, Marc, et al.
Publicado: (2012)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
por: Strain, W. David, et al.
Publicado: (2019)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
por: Bennett, Hayley, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pkl9qrv015i0bdb36hjvot3q5n